SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs concludes USFDA inspection of Visakhapatnam API facilities with 2 observations

19 Aug 2017 Evaluate

Laurus Labs has completed the US Food and Drug Administration (USFDA) inspection of its API facilities in Unit 1 and 3 in Parawada, Visakhapatnam, Andhra Pradesh, with two observations. This is a regular surveillance audit by USFDA, and the observations are procedural in nature and no data integrity issues were observed.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.


Laurus Labs Share Price

1163.50 -3.00 (-0.26%)
05-May-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.80
Dr. Reddys Lab 1276.75
Cipla 1330.25
Zydus Lifesciences 907.55
Lupin 2331.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×